Study: Lockdown Slowed Spread In Rhode Island; Many Still At Risk, Though
State news from Rhode Island, Georgia, California, Texas and Louisiana.
The independent source for health policy research, polling, and news.
19,241 - 19,260 of 112,745 Results
State news from Rhode Island, Georgia, California, Texas and Louisiana.
Other health industry news on bonuses for executives, the Provider Relief Fund, cancer treatments, health insurers and more.
Also: Colorado tackles racism; homicides spike in large cities; Maine battles rabies outbreak; the anniversary of the El Paso, Texas, shooting; West Nile virus; and more.
Personal health issues are reported about Supreme Court Justice Ruth Bader Ginsburg and Pope Emeritus Benedict XVI. And the first person to receive a face transplant dies.
A NFL coach tests positive, and a few college players threaten to boycott games. But there is some good news: Drew Brees, the New Orleans Saints quarterback, has stopped licking his fingers.
Hundreds may have been exposed to those aboard the MS Roald Amundsen, officials say. In other public health news: a D.C. priest contracts COVID after preaching against it; Latinx communities suffer in the pandemic; the lack of health literacy; and more.
A broad survey of universities reveals that the coronavirus has already affected the institutions -- even before classes have resumed. The schools struggle with how to cope.
More schools report COVID cases and parents understandably fret. And President Trump's son's private school in Maryland remains closed.
The money comes from a $1.5 billion pot allocated to the NIH in April and is intended to add 6 million tests a year. Technology news is on antibody tests and more.
Scientists and public health officials worry that people have unrealistic views of how a coronavirus vaccine would roll out. Others wrestle with the question of who gets inoculated first. Other vaccine news covers income disparity, clinical trials and more.
COVID-19 patients recovered rapidly from respiratory failure after three days of treatment with RLF-100, or aviptadil, Reuters reports. Also in the news: CytoDyn, GoodRx and Catalyst.
While the economic damage of the COVID epidemic grows, the debate has resumed whether the country would be better off financially if it went on a brief, but intense, lockdown.
As predictions of a shortage of poll workers grow, adding to the anxiety of a well-run election in November, House Speaker Nancy Pelosi said mail-in voting will be an essential option for Americans‘ safety.
The White House and congressional Democrats remain far apart on measures that should be included in the next round of coronavirus relief legislation as negotiations resume.
After finding out about the positive coronavirus test, Rep. Raúl Grijalva (D-Arizona) called out Republican members who "routinely strut around the Capitol without a mask to selfishly make a political statement at the expense of their colleagues, staff, and their families."
The latest deal by the U.S. federal government pays $2.1 billion to Sanofi and GlaxoSmithKline for COVID-19 vaccine development and delivery of 100 million doses, if successful.
As the nation's top public health officials appeared before a House committee, Dr. Anthony Fauci also said he's "cautiously optimistic" about a vaccine this year.
"I want to be very clear: What we are seeing today is different from March and April," Dr. Deborah Birx, the White House coronavirus task force coordinator, said during a CNN interview. "It is extraordinarily widespread. This epidemic right now is different ... and it's both rural and urban."
While new cases dipping give reason for cautious optimism, the fatality rate from COVID-19 maintained grim levels. A new model forecasts that the U.S. could pass 180,000 deaths this month.
Today's early morning highlights from the major news organizations.
© 2026 KFF